PDEs and GPCRs

Innovative, drug-like small molecules have been successfully identified as inhibitors of phosphodiesterases and as modulators of G-coupled protein receptors. With the focused compound libraries high hit-rates have been achieved for both target classes.  

Who are we?


Discover Asclepia
Let us help you to grow your business!


T:  +32 474 48 71 50

M:  petra.blom@asclepia.com